Pasithea Therapeutics announced positive Phase 1 clinical data for PAS-004, a new oral MEK inhibitor, showing prolonged stable disease in heavily pre-treated advanced cancer patients, including those with BRAF V600E mutations resistant to prior therapies. Four patients remained on treatment for over 300 days, with two exceeding 500 days. The drug demonstrated a favorable safety profile with no severe treatment-related adverse events or discontinuations, and a pharmacokinetic profile supporting once-daily dosing. These results, presented at ESMO Congress 2026, suggest PAS-004 could offer durable benefit and tolerability for patients with MAPK pathway-driven tumors and potentially chronic conditions like neurofibromatosis type 1.
Pasithea Therapeutics' positive Phase 1 clinical data for PAS-004 provides context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 23, 2026 20:21 WIB: out of 150 priced health-sector US stocks tradable on Pluang, 28 rose and 119 fell today. Notable movers include BTSG at USD 60.01 with a -1.40% change and a typical hold time of 14 days, DYN at USD 15.55 down -1.40% with 100% sell order activity and a 4-day hold time, and INO at USD 0.85 up 1.32% with 73% sell and 27% buy order activity and a 43-day hold time.
FS Bancorp, Inc. has appointed Matthew D. Mullet as a director on the boards of both the company and its bank, 1st Security Bank of Washington, effective October 22, 2026. Mullet, who has been President since 2024 and CEO since 2025-2026, brings exte...
The global protein ingredients market, valued at $42.3 billion in 2025, is projected to grow to $65 billion by 2032 with a CAGR of 6.3%. Growth is driven by rising consumer demand for health-focused, protein-enriched foods, sports nutrition, and sust...
AX1 has launched Console 2.0, a platform on the Base blockchain that lets AI agents perform tasks and get paid in USDC using the x402 payment standard by Coinbase. This new version simplifies setup, allowing users to deploy AI agents quickly to work ...
The global generator cooling systems market is projected to grow from $3.76 billion in 2026 to $5.03 billion by 2031 at a CAGR of 6.0%. Growth is fueled by rising demand for reliable backup and continuous power in expanding data centers, industrial f...
The global computed tomography (CT) market is undergoing significant innovation driven by photon-counting technology, AI integration, mobile imaging, and point-of-care applications. These advancements are enhancing image quality, workflow efficiency,...
